Publicaciones

The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy.

Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.

Update of the drug resistance mutations in HIV-1: Fall 2006.

Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.

Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.

[Resistance genotyping in patients with therapeutic failure].

Evidence for preferential genotyping of a minority human immunodeficiency virus population due to primer-template mismatching during PCR-based amplification.

Evaluation of the anti-HIV activity of statins.

[Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].